History
  • No items yet
midpage
The Dow Chemical Company v. Nova Chemicals Corporation
809 F.3d 1223
Fed. Cir.
2015
Read the full case

Background

  • Dow sued NOVA for patent infringement; a jury previously found the patent valid and infringed and damages were awarded.
  • The district court entered a Rule 54(b) partial final judgment on validity, infringement, and damages; further proceedings addressed supplemental/post-verdict royalties.
  • After the earlier appeal affirmed liability, a later district-court judgment fixing supplemental royalties was appealed; during that interval the Supreme Court decided Nautilus (new definiteness standard).
  • A panel subsequently addressed indefiniteness under Nautilus and concluded the asserted claim term was indefinite, reversing prior determinations; Dow sought rehearing en banc.
  • The court denied rehearing en banc; separate opinions (concurrences and a dissent) discuss (1) whether the panel changed indefiniteness law, (2) deference to subsidiary fact findings, (3) burden of proof, and (4) appellate jurisdiction/finality under Rule 54(b) and Bosch.

Issues

Issue Plaintiff's Argument (Dow) Defendant's Argument (NOVA) Held
Proper role of extrinsic evidence in indefiniteness Extrinsic evidence should not resolve which measurement method to use; panel erred if it relied on such evidence to find indefiniteness Extrinsic evidence is appropriate to show what a skilled artisan would understand; measurement method can be established by art knowledge Concurrences: extrinsic evidence may be relevant; panel did not eliminate its use; factual issues about skilled artisan can be proven extrinsically
Standard of review for underlying fact findings Panel applied de novo review and failed to defer to district/jury fact findings Subsidiary fact findings that rely on extrinsic evidence are entitled to clear-error or substantial-evidence deference Courts reaffirm deference: Teva requires deference to fact findings; panel cannot overrule that precedent
Burden of proof for indefiniteness Burden should shift or be relaxed given Nautilus Burden remains on challenger to prove invalidity by clear and convincing evidence under 35 U.S.C. § 282 Held: burden remains on challenger and standard is clear and convincing; Dow did not change that law
Jurisdiction/finality: could panel revisit previously decided validity after Rule 54(b) final judgment? Panel had authority to address definiteness in the supplemental-damages appeal The appeal was limited to a ministerial accounting/royalty determination after a final Rule 54(b) judgment; reopening validity violates finality and rule against addressing issues not in the appealed judgment Dissent: panel lacked jurisdiction to reopen an affirmed final judgment under Rule 54(b); the court denied rehearing en banc but dissent urges en banc review on finality grounds

Key Cases Cited

  • Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831 (2015) (subsidiary factual findings underlying claim construction are reviewed for clear error)
  • Nautilus, Inc. v. Biosig Instruments, Inc., 134 S. Ct. 2120 (2014) (redefined indefiniteness standard requiring reasonable certainty)
  • Microsoft Corp. v. i4i Ltd. P’ship, 564 U.S. 91 (2011) (clear-and-convincing standard applies to patent invalidity challenges)
  • Teva Pharm. USA, Inc. v. Sandoz, Inc., 789 F.3d 1335 (Fed. Cir. 2015) (post-Teva panel applying clear-error review to indefiniteness fact findings)
  • Interval Licensing LLC v. AOL, Inc., 766 F.3d 1364 (Fed. Cir. 2014) (indefiniteness may be reviewed de novo where only intrinsic evidence is relied upon)
  • W.L. Gore & Assoc., Inc. v. Garlock, Inc., 721 F.2d 1540 (Fed. Cir. 1983) (definiteness evaluated in light of knowledge in the art at the time of filing)
  • American Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350 (Fed. Cir. 1984) (patent validity presumed; burden of proving invalidity rests on challenger)
  • Robert Bosch, LLC v. Pylon Mfg. Corp., 719 F.3d 1305 (Fed. Cir. 2013) (discussing finality and appeals from liability determinations with outstanding damages/willfulness issues)
Read the full case

Case Details

Case Name: The Dow Chemical Company v. Nova Chemicals Corporation
Court Name: Court of Appeals for the Federal Circuit
Date Published: Dec 17, 2015
Citation: 809 F.3d 1223
Docket Number: 2014-1431, 2014-1462
Court Abbreviation: Fed. Cir.